{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:58:13Z","timestamp":1778432293917,"version":"3.51.4"},"reference-count":23,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,26]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Refractory cytopenia of childhood (RCC) describes an entity of well-recognized bone marrow failure defined by persistent cytopenia, dysplastic changes, and a unique histopathological pattern in the bone marrow. Although hematopoietic stem cell transplantation (HSCT) is generally indicated for patients with severe cytopenia or abnormal karyotype, a subset of patients with RCC may be candidates for an observational approach. We evaluated the long-term outcome of patients with RCC without evidence of a genetic predisposition who had a normal karyotype and had not received HSCT or immunosuppressive therapy within 2 years from diagnosis. The median age at diagnosis of the 100 patients analyzed was 10.9 years (range 1.4-17.3); 84% presented with a hypocellular bone marrow. Clonal evolution with abnormal karyotype occurred in 3 patients (3%), and 1 case progressed to myelodysplastic syndrome with excess blasts. Three patients (3%) developed paroxysmal nocturnal hematuria. Overall, 9 patients (9%) received HSCT, and the 5- and 10-year HSCT-free survival was 94% and 88%, respectively. At last follow-up, all patients were alive with a median follow-up time of 7.2 years. These results indicate that an observational approach is safe for selected patients with RCC with a normal karyotype after an exclusion of a germ line predisposition syndrome. However, persistence of cytopenia in most of these patients underscores the importance of long-term surveillance and transition to adult hematology care. This trial was registered at www.clinicaltrials.gov as #NCT00047268 and #NCT00662090.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016136","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T12:56:53Z","timestamp":1750769813000},"page":"4279-4285","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Long-term outcomes of patients with refractory cytopenia of childhood under observation only"],"prefix":"10.1182","volume":"9","author":[{"given":"Beatrice","family":"Drexler","sequence":"first","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"2Division of Hematology, University Hospital Basel, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Schwarz-Furlan","sequence":"additional","affiliation":[{"name":"3Institute of Pathology, Klinikum Kaufbeuren-Ravensburg, Kaufbeuren, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irith","family":"Baumann","sequence":"additional","affiliation":[{"name":"3Institute of Pathology, Klinikum Kaufbeuren-Ravensburg, Kaufbeuren, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Rudelius","sequence":"additional","affiliation":[{"name":"4Institute of Pathology, Ludwig-Maximilians-Universit\u00e4t of Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0281-4732","authenticated-orcid":false,"given":"Peter","family":"N\u00f6llke","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Lebrecht","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-4247","authenticated-orcid":false,"given":"Senthilkumar","family":"Ramamoorthy","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"5Faculty of Medicine, Institute of Medical Bioinformatics and Systems Medicine, University Medical Center Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rotari","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Karow","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"7Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, University of Hokkaido, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Beier","sequence":"additional","affiliation":[{"name":"9Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Rheinisch-Westf\u00e4lische Technische Hochschule Aachen University, Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne Lisa","family":"Behrens","sequence":"additional","affiliation":[{"name":"10Department of Human Genetics, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"G\u00f6hring","sequence":"additional","affiliation":[{"name":"10Department of Human Genetics, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-6907","authenticated-orcid":false,"given":"Reinhard","family":"Kalb","sequence":"additional","affiliation":[{"name":"11Department of Human Genetics, University of W\u00fcrzburg Biocenter, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"12Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-130X","authenticated-orcid":false,"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-1447","authenticated-orcid":false,"given":"Miriam","family":"Erlacher","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"13Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-7937","authenticated-orcid":false,"given":"Charlotte M.","family":"Niemeyer","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"14German Cancer Consortium, Partner Site Freiburg, a partnership between Deutsche Krebsforschungszentrum and University Medical Center Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1593-9507","authenticated-orcid":false,"given":"Ayami","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"1Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children\u2019s Hospital, Medical Center\u2013University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"6","key":"2025082608320381900_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11899-019-00547-3","article-title":"The clinical challenge of idiopathic cytopenias of undetermined significance (ICUS) and clonal cytopenias of undetermined significance (CCUS)","volume":"14","author":"Steensma","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"key":"2025082608320381900_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and other acronyms: definition, implications, and impact on practice","volume":"39","author":"DeZern","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"2025082608320381900_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2011.04156.x","article-title":"Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria","volume":"61","author":"Baumann","year":"2012","journal-title":"Histopathology"},{"issue":"1","key":"2025082608320381900_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00428-022-03447-9","article-title":"The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia","volume":"482","author":"Rudelius","year":"2023","journal-title":"Virchows Arch"},{"issue":"11","key":"2025082608320381900_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2025082608320381900_bib6","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1038\/s41375-022-01731-w","article-title":"Classification of rare pediatric myeloid neoplasia-Quo vadis?","volume":"36","author":"Niemeyer","year":"2022","journal-title":"Leukemia"},{"key":"2025082608320381900_bib7","first-page":"430","article-title":"Gene mutations of the telomerase complex in patients presenting with refractory cytopenia of childhood (RCC) \u2013 do we need to know?","volume":"96","author":"Karow","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"2025082608320381900_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bjh.12083","article-title":"High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood","volume":"160","author":"Yoshimi","year":"2013","journal-title":"Br J Haematol"},{"issue":"11","key":"2025082608320381900_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2025082608320381900_bib10","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"issue":"4","key":"2025082608320381900_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3324\/haematol.2013.095786","article-title":"Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood","volume":"99","author":"Yoshimi","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"2025082608320381900_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12185-014-1674-z","article-title":"Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan","volume":"100","author":"Moriwaki","year":"2014","journal-title":"Int J Hematol"},{"issue":"6","key":"2025082608320381900_bib13","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2002-11-3444","article-title":"Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7","volume":"102","author":"Kardos","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2025082608320381900_bib14","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1038\/bcj.2014.28","article-title":"T-cell receptor V\u03b2 skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS","volume":"4","author":"Aalbers","year":"2014","journal-title":"Blood Cancer J"},{"issue":"1","key":"2025082608320381900_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/leu.2013.195","article-title":"The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS","volume":"28","author":"Aalbers","year":"2014","journal-title":"Leukemia"},{"issue":"13","key":"2025082608320381900_bib16","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2017-09-765214","article-title":"How I treat myelodysplastic syndromes of childhood","volume":"131","author":"Locatelli","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2025082608320381900_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","article-title":"Genetics of human telomere biology disorders","volume":"24","author":"Revy","year":"2023","journal-title":"Nat Rev Genet"},{"key":"2025082608320381900_bib18","first-page":"104","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid tissues","author":"Baumann","year":"2008"},{"key":"2025082608320381900_bib19","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Baumann","year":"2017","edition":"Revised 4th ed"},{"issue":"4","key":"2025082608320381900_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/his.15378","article-title":"Diagnostic features in paediatric MDS-EB with UBTF-internal tandem duplication: defining a unique subgroup","volume":"86","author":"Schwarz-Furlan","year":"2025","journal-title":"Histopathology"},{"issue":"282","key":"2025082608320381900_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2025082608320381900_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(79)80344-3","article-title":"Percentile curves for hemoglobin and red cell volume in infancy and childhood","volume":"94","author":"Dallman","year":"1979","journal-title":"J Pediatr"},{"issue":"5","key":"2025082608320381900_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bjh.12955","article-title":"Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification","volume":"166","author":"Hasegawa","year":"2014","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/16\/4279\/2407781\/blooda_adv-2025-016136-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/16\/4279\/2407781\/blooda_adv-2025-016136-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T12:32:09Z","timestamp":1756211529000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/16\/4279\/537904\/Long-term-outcomes-of-patients-with-refractory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,8,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016136","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,26]]},"published":{"date-parts":[[2025,8,18]]}}}